Literature DB >> 11165734

The origin of spermatozoa does not affect intracytoplasmic sperm injection outcome.

O Bukulmez1, A Yucel, H Yarali, I Bildirici, T Gurgan.   

Abstract

OBJECTIVE: To assess whether the origin of spermatozoa, ejaculate or testicular, affects intracytoplasmic sperm injection (ICSI) outcome. STUDY
DESIGN: Retrospective study of 890 consecutive first ICSI and embryo transfer cycles done for male infertility. The ICSI outcome of ejaculated spermatozoa (n=780) and testicular spermatozoa retrieved from patients with obstructive azoospermia (n=43), non-obstructive azoospermia (n=53) and severe oligoasthenoteratozoospermia (n=14) were compared by using chi-square test, independent t-test and ANOVA with Bonferroni test.
RESULTS: All azoospermic males had a diagnostic testicular biopsy at least 6 months before the ICSI procedure. Spermatozoa were successfully retrieved in all 43 patients with obstructive azoospermia and in 72.6% of 73 non-obstructive cases. The cycle characteristics of the four groups were similar apart from a younger mean female age in the non-obstructive azoospermia group when compared with the ejaculated spermatozoa group. The fertilization, implantation and clinical pregnancy rates were comparable among the four groups.
CONCLUSION: Testicular spermatozoa recovered from patients with obstructive and all types of non-obstructive azoospermia were as much as effective as ejaculated spermatozoa in ICSI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165734     DOI: 10.1016/s0301-2115(00)00347-x

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation.

Authors:  Yue-hong Lu; Hui-juan Gao; Bai-jia Li; Ying-ming Zheng; Ying-hui Ye; Yu-li Qian; Chen-ming Xu; He-feng Huang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

2.  The effects of sperm quality on embryo development after intracytoplasmic sperm injection.

Authors:  Kalliopi E Loutradi; Basil C Tarlatzis; Dimitrios G Goulis; Leonidas Zepiridis; Thoula Pagou; Elisabeth Chatziioannou; Grigoris F Grimbizis; Ioannis Papadimas; Ioannis Bontis
Journal:  J Assist Reprod Genet       Date:  2006-03-31       Impact factor: 3.412

3.  Fresh MESA improved embryo fertilization, cleavage, blastula formation and implantation rates after failed TESA in couples with obstructive azoospermia.

Authors:  Martin D Keltz; Elisheva M Rovner; Eric Gonzalez; David Weiner
Journal:  J Assist Reprod Genet       Date:  2011-01-07       Impact factor: 3.412

4.  In cryptozoospermia or severe oligozoospermia is sperm freezing useful?

Authors:  Julien Bessonnat; Sophie Brouillet; Sarah Sintzel; Pierre Gillois; Ulrike Bergues; Caroline Boutte-Busquet; Claire Thomas-Cadi; Sylviane Hennebicq
Journal:  Basic Clin Androl       Date:  2014-10-02

5.  Comparison of Intracytoplasmic Sperm Injection Outcomes between Oligozoospermic, Obstructive Azoospermic and Non-Obstructive Azoospermic Patients.

Authors:  Ensieh Shahrokh Tehraninejad Tehraninejad; Elham Pourmatroud; Mohammad Ali Sadighi Gilani; Mahdi Rakebi; Zahra Azimi Neko; Arezoo Arabipoor
Journal:  Int J Fertil Steril       Date:  2012-06-19

6.  Novel method of histopathological analysis after testicular sperm extraction in patients with nonobstructive and obstructive azoospermia.

Authors:  Gianmartin Cito; Maria Elisabetta Coccia; Rita Picone; Gabriella Nesi; Andrea Cocci; Sara Dabizzi; Giulio Garaffa; Rossella Fucci; Patrizia Falcone; Francesco Bertocci; Raffaella Santi; Luciana Criscuoli; Sergio Serni; Marco Carini; Alessandro Natali
Journal:  Clin Exp Reprod Med       Date:  2018-11-30

Review 7.  Reproductive outcomes, including neonatal data, following sperm injection in men with obstructive and nonobstructive azoospermia: case series and systematic review.

Authors:  Sandro C Esteves; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.